Although not fully understood, it is generally considered that MYCN amplification is an early event in NB development that drives tumorigenic transformation in neural crest-derived cells, resulting in stem cell-like traits, for example, self-renewal, resistance to apoptosis and metabolic changes. This evidence concerns the gene MYCN and neuroblastoma.